Nucleic acid sequencing

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S008000, C536S024300

Reexamination Certificate

active

08008002

ABSTRACT:
A method is disclosed for determining a target nucleic acid sequence, where the target nucleic acid sequence is comprised in a preparation comprising a non-target nucleic acid sequence, the target nucleic acid sequence and the non-target nucleic acid sequence each having a first region of common sequence upstream of a first region of dissimilar sequence upstream of a second region of dissimilar sequence, and includes the steps of contacting the preparation with an oligonucleotide primer complementary to at least a portion of the first region of common sequence, under conditions to hybridise the primer thereto; contacting the preparation with a first labelled nucleotide bearing a first label, wherein the first labelled nucleotide is complementary to a first template nucleotide comprised in the first region of dissimilar sequence of either the target nucleic acid sequence or the non-target nucleic acid sequence, under conditions to incorporate the first labelled nucleotide either into the primer hybridised to the target nucleic acid sequence or into the primer hybridised to the non-target nucleic acid sequence but not into both; and subjecting the preparation to a sequencing reaction, thereby extending the primer to form one or more first-labelled sequencing products comprising the first labelled nucleotide and one or more non-first-labelled sequencing products comprising no first labelled nucleotide; and determining at least a portion of the sequence of the first-labelled sequencing products and/or the non-first-labelled sequencing products, thereby determining at least the second region of dissimilar sequence of the target nucleic acid sequence.

REFERENCES:
patent: 2001/0031467 (2001-10-01), Dapprich et al.
patent: WO 92/15711 (1992-09-01), None
patent: WO 93/23562 (1993-11-01), None
patent: WO 94/01447 (1994-01-01), None
patent: WO 95/15974 (1995-06-01), None
patent: WO 97/23650 (1997-07-01), None
patent: WO 97/46711 (1997-12-01), None
patent: WO 98/13523 (1998-04-01), None
patent: WO 98/28440 (1998-07-01), None
patent: WO 00/20628 (2000-04-01), None
patent: WO 00/66604 (2000-11-01), None
patent: WO 01/90419 (2001-11-01), None
patent: WO 0190419 (2001-11-01), None
patent: WO 02/20837 (2002-03-01), None
patent: WO 03/095664 (2003-11-01), None
patent: WO 2004/001015 (2003-12-01), None
Ronaghi et al., “A Sequencing Method based on Real-Time Pyrophosphate”, in: Science, vol. 281, Jul. 17, 1998.
Kaneoka et al., “Solid-Phase Direct DNA Sequencing of Allele-Specific Polymerase Chain Reaction—Amplified HLA-DR Genes”, in: Biotechniques, vol. 10, No. 1, 1991.
Finckh et al., Allele-specific PCR for simultaneous amplification of both alleles of a deletion polymorphism in intron 6 of the human dopamine 2 receptor gene (DRD2), in: DNA Sequence—The Journal of Sequencing and Mapping, vol. 6, pp. 87-94, 1996.
Sanger et al., “DNA Sequencing with chain-terminating inhibitors”, in: Proc. Natl. Acad. Sci., vol. 74, No. 12, pp. 5463-5467, Dec. 1977.
Alderborn et al., “Determination of Single-Nucleotide Polymorphisms by Real-time Pyrophosphate DNA Sequencing”, in: Genome Research, vol. 10, 2000, pp. 1249-1258.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Nucleic acid sequencing does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid sequencing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid sequencing will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2727305

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.